• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

Introduction to 3-cyclobutyl-1-oxo-2,8-dioxaspiro4.5decane-3-carboxylic acid (CAS No. 2171888-48-3)

3-cyclobutyl-1-oxo-2,8-dioxaspiro4.5decane-3-carboxylic acid, identified by the chemical identifier CAS No. 2171888-48-3, is a compound of significant interest in the field of medicinal chemistry and synthetic organic chemistry. This spirocyclic dioxane derivative features a unique structural framework that has garnered attention for its potential applications in drug discovery and material science. The presence of a cyclobutyl group and a carboxylic acid functionality within the spirocyclic core imparts distinct chemical properties that make it a valuable scaffold for further derivatization and investigation.

The molecular structure of 3-cyclobutyl-1-oxo-2,8-dioxaspiro4.5decane-3-carboxylic acid consists of an spirocyclic connection between a dioxane ring and a decane backbone, with the cyclobutyl substituent attached to the dioxane ring at the 3-position. The carboxylic acid group is located at the same position, providing a reactive site for further functionalization. This structural motif is particularly intriguing because it combines the rigidity of the cyclobutyl ring with the flexibility of the spirocyclic system, which can influence both electronic and steric properties.

In recent years, there has been growing interest in spirocyclic compounds due to their potential as bioactive molecules. Spirocycles are known for their ability to exhibit conformational preorganization, which can enhance binding affinity and selectivity in biological targets. The spirocyclic core of 3-cyclobutyl-1-oxo-2,8-dioxaspiro4.5decane-3-carboxylic acid is particularly well-suited for such applications, as it can provide a stable scaffold while allowing for modifications at multiple positions.

The carboxylic acid functionality at the 3-position of the molecule is another key feature that makes this compound attractive for medicinal chemistry applications. Carboxylic acids are versatile handles that can be used to form esters, amides, or other derivatives, enabling the synthesis of a wide range of bioactive molecules. Additionally, the presence of an oxo group (a ketone) within the dioxane ring introduces another site for chemical modification, further expanding the synthetic possibilities.

Recent studies have begun to explore the pharmacological potential of spirocyclic dioxanes, including derivatives similar to 3-cyclobutyl-1-oxo-2,8-dioxaspiro4.5decane-3-carboxylic acid. These studies have highlighted the ability of such compounds to interact with various biological targets, including enzymes and receptors involved in metabolic pathways and signal transduction. For instance, some research has suggested that spirocyclic dioxanes may have inhibitory effects on certain enzymes by mimicking natural substrates or by inducing conformational changes in protein structures.

The cyclobutyl group in this compound also plays a crucial role in determining its chemical behavior. The cycloalkyl substituents are known to influence both electronic and steric properties, which can affect reactivity and binding interactions. In particular, the cyclobutyl ring can introduce steric hindrance that may enhance or diminish binding affinity depending on the target site. This feature makes 3-cyclobutyl-1-oxo-2,8-dioxaspiro4.5decane-3-carboxylic acid a promising candidate for structure-based drug design.

Synthetic approaches to constructing this molecule have been explored in several research groups. The spirocyclic core typically requires multi-step syntheses involving cyclization reactions followed by functional group transformations. Advances in synthetic methodology have made it possible to construct complex spirocyclic systems more efficiently, which has spurred interest in exploring new derivatives like 3-cyclobutyl-1-oxo-2,8-dioxaspiro4.5decane-3-carboxylic acid.

In conclusion, 3-cyclobutyl-1-oxo-2,8-dioxaspiro4.5decane-3-carboxylic acid (CAS No. 2171888-48-3) represents an intriguing compound with potential applications in drug discovery and material science. Its unique structural features—comprising a spirocyclic core, an oxo group, a carboxylic acid functionality, and a cyclobutyl substituent—make it a versatile scaffold for further investigation and derivatization. As research continues to uncover new pharmacological targets and synthetic strategies, compounds like this are likely to play an increasingly important role in developing novel therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)